dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
Published 5 years ago • 813 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
2:09
dr. oh on the enzamet trial in mhspc
-
1:09
dr. sweeney on chemotherapy in prostate cancer
-
1:40
evaluating significance of enzamet trial in metastatic hormone-sensitive prostate cancer
-
1:20
dr. sweeney on evolving role of chemotherapy for hormone-sensitive prostate cancer
-
6:05
enzamet trial
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:55
dr. sweeney on chemotherapy versus abiraterone for mcrpc
-
1:45
dr. sweeney discusses tailoring treatment in prostate cancer
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
1:10
dr. davis discusses anzup collaboration on the enzamet trial in prostate cancer
-
9:23
hormone-sensitive metastatic prostate cancer
-
5:20
hormone-sensitive prostate cancer
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
2:05
dr. kohli on sequencing concerns in metastatic hormone-sensitive prostate cancer
-
7:00
hormone-sensitive prostate cancer: nuances in therapy
-
6:02
update on the arches trial: new indication for enzalutamide in mhspc
-
1:35
arches: os by high or low disease volume and progression to mhspc or de novo mhspc
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
1:06:24
metastatic hormone sensitive prostate cancer